SKI Market

Indian Indices

Nifty

24,750.70 -82.90
(-0.33%)

Sensex

81,254.82 -196.19
( -0.24%)

Bank Nifty

55,749.70 203.65
( 0.37%)

Nifty IT

37,321.75 -432.40
( -1.15%)

Global Indices

Nasdaq

42,280.67 43.94
(0.10%)

Dow Jones

5,931.28 -1.89
(-0.03%)

Hang Seng

38,097.61 -335.37
(-0.87%)

Nikkei 225

8,772.38 55.93
(0.64%)

Forex

USD-INR

85.50 0.07
(0.09%)

EUR-INR

97.01 0.42
(0.44%)

GBP-INR

115.18 0.03
(0.03%)

JPY-INR

0.59 0.00
(0.53%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Industry :

BSE Code

ISIN Demat

Book Value()

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EPS(TTM)

Face Value()

Div & Yield %

Back

itc ltd

ANG Lifesciences India reports consolidated net loss of Rs 2.09 crore in the September 2024 quarter

Nov 15,2024

Net Loss of ANG Lifesciences India reported to Rs 2.09 crore in the quarter ended September 2024 as against net loss of Rs 2.32 crore during the previous quarter ended September 2023. Sales declined 1.14% to Rs 32.88 crore in the quarter ended September 2024 as against Rs 33.26 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	32.88	33.26	-1
OPM %	6.96	4.99	-
PBDT	0.45	-0.41	LP
PBT	-1.29	-2.63	51
NP	-2.09	-2.32	10

24,750.70 -82.90 (-0.33%)

81,254.82 -196.19 ( -0.24%)

55,749.70 203.65 ( 0.37%)

37,321.75 -432.40 ( -1.15%)

42,280.67 43.94 (0.10%)

5,931.28 -1.89 (-0.03%)

38,097.61 -335.37 (-0.87%)

8,772.38 55.93 (0.64%)

85.50 0.07 (0.09%)

97.01 0.42 (0.44%)

115.18 0.03 (0.03%)

0.59 0.00 (0.53%)